[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100421985":3},{"organization":4,"armGroups":7,"interventions":18,"overallOfficials":26,"centralContacts":31,"locations":41,"responsibleParty":59,"collaborators":63,"id":77,"slug":35,"hasResults":78,"nctId":79,"briefTitle":80,"officialTitle":81,"acronym":82,"eligibilityCriteria":83,"healthyVolunteers":78,"sex":84,"minAge":85,"maxAge":86,"enrollmentInfo":87,"targetDuration":35,"studyType":90,"phases":91,"briefSummary":93,"conditions":94,"keywords":35,"overallStatus":96,"whyStopped":35,"lastUpdateSubmitDate":97,"lastUpdatePostDateStruct":98,"startDateStruct":101,"completionDateStruct":103,"leadSponsor":105,"locationsCount":106},{"fullName":5,"class":6},"Turku University Hospital","OTHER_GOV",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"EVLA only","ACTIVE_COMPARATOR","Only main trunk\u002Ftrunks with venous reflux will be treated",[13],"Procedure: Endovenous laser ablation",{"label":15,"type":10,"description":16,"interventionNames":17},"EVLA and sclerotherapy of tributaries","Main trunk\u002Ftrunks with venous reflux will be treated combined with foam sclerotherapy",[13],[19],{"type":20,"name":21,"description":22,"armGroupLabels":23,"otherNames":24},"PROCEDURE","Endovenous laser ablation","The aim is to combine the significance of for sclerotherapy at the primary EVLA treatment",[15,9],[25],"Endovenous laser ablation combined with foam sclerotherapy of varicose tributaries",[27],{"name":28,"affiliation":29,"role":30},"Harri Hakovirta, Professor","University of Turku","STUDY_CHAIR",[32,37],{"name":28,"role":33,"phone":34,"phoneExt":35,"email":36},"CONTACT","+358405918811",null,"haheha@utu.fi",{"name":38,"role":33,"phone":39,"phoneExt":35,"email":40},"Khalil Firoozi, MD","+35823130000","khalil.firoozi@tyks.fi",[42],{"facility":5,"status":35,"city":43,"state":35,"zip":44,"country":45,"cosmosGeoPoint":46,"geoPoint":51,"contacts":52},"Turku","20520","Finland",{"type":47,"coordinates":48},"Point",[49,50],22.26869,60.45148,{"lat":50,"lon":49},[53,55,56],{"name":28,"role":33,"phone":39,"phoneExt":35,"email":54},"harri.hakovirta@tyks.fi",{"name":38,"role":33,"phone":39,"phoneExt":35,"email":40},{"name":57,"role":58,"phone":35,"phoneExt":35,"email":35},"Jaakko Viljamaa, MD","SUB_INVESTIGATOR",{"type":60,"investigatorFullName":61,"investigatorTitle":62,"investigatorAffiliation":5,"oldNameTitle":35,"oldOrganization":35},"PRINCIPAL_INVESTIGATOR","Khalil Firoozi","MD",[64,67,69,71,73,75],{"name":65,"class":66},"Helsinki University Central Hospital","OTHER",{"name":68,"class":66},"Oulu University Hospital",{"name":70,"class":66},"Tampere University Hospital",{"name":72,"class":66},"Päijänne Tavastia Central Hospital",{"name":74,"class":66},"Satasairaala",{"name":76,"class":66},"Vaasa Central Hospital, Vaasa, Finland","100421985",false,"NCT04774939","EVLA and Optimal Timing of Sclerotherapy","FinnTrunk, EVLA and Optimal Timing of Sclerotherapy","FinnTrunk","Inclusion Criteria:\n\n* Varicose disease of lower extremity caused by reflux of VSM, SSV or AASV to be treated with EVLA. Age over 18 years. Clinical symptoms C2-3.\n\nExclusion Criteria:\n\n* No severe comorbidities. Previous DVT.","ALL","18 Years","99 Years",{"count":88,"type":89},350,"ESTIMATED","INTERVENTIONAL",[92],"NA","The aim of the study is to investigate the optimal timing of sclerotherapy for treatment of varicose tributaries on EVLA (endogenous laser ablation) patients.",[95],"Venous Reflux","NOT_YET_RECRUITING","2021-02-24",{"date":99,"type":100},"2021-03-01","ACTUAL",{"date":102,"type":89},"2021-03-15",{"date":104,"type":89},"2030-03-15",{"name":5,"class":6},1]